NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 9:20 PM

Adeona

Type: Keyphrase

Name: Adeona

First Reported 11/17/2009 - Updated 11/17/2009 - 2 Documents (in Health)

Adeona Pharmaceuticals Announces Third Quarter 2009 Results and Achievements

Companies mentioned in this article: Adeona Pharamaceuticals, Inc.ANN ARBOR, MI -- (Marketwire) -- 11/17/09 -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment ... [Freshnews.com - 11/17/2009]

Entities: Adeona, Copper, Alzheimer's Disease

First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Biotechnology)

BRIEF-Adeona Pharmaceuticals Q3 results

Nov 17 (Reuters) - Adeona Pharmaceuticals Inc:* Announces third quarter 2009 results and achievements* Q3 loss per share $0.03((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))(For more news, please click here)COPYRIGHT ... [Forbes.com - 11/17/2009]

Entities: Adeona, Bangalore, United States

First Reported 11/14/2009 - Updated 11/14/2009 - 1 Documents

Maxygen Buying Back Stock; Analysts Say No Trend Here

Too Much Cash? In Biotech? By Trista Morrison Staff WriterMaxygen Inc. on Friday became the latest member of a very small biotech cadre that is returning cash to shareholders.In the biotech world of sky-high drug development costs and endless opportunities ... [BioWorld - 11/14/2009]

Entities: Maxygen Incorporated, Cardiome Pharma Corp, Biotechnology, Kynapid, Adeona

First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents

Adeona Pharmaceuticals Announces Third Quarter 2009 Results and Achievements

A webcast has been scheduled for 9:00 AM EST. Participants my view the audio/visual presentation by either pasting the following link into their browser, http://www.visualwebcaster.com/event.asp?id=64101United States participants wishing to join the call ... [Yahoo! Canada - 11/17/2009]

Entities: Adeona, Lyon (France), United States

First Reported 11/13/2009 - Updated 11/13/2009 - 3 Documents (in Biology)

Adeona Pharmaceuticals (AEN) Gives Positive Clinical Data on Arthritis Drug

ANN ARBOR, MI--(Marketwire - 11/13/09) - Adeona Pharmaceuticals, Inc. (AMEX:AEN - News) announced today the publication in the journal Arthritis & Rheumatism of results of a 160-patient, six-month, double-blind, placebo-controlled Phase 2 clinical trial ... [BioSpace - 11/13/2009]

Entities: Adeona, Rheumatoid Arthritis, Arthritis, Clinical Data Inc

First Reported 11/02/2009 - Updated 11/02/2009 - 2 Documents (in Health)

Adeona Receives IRB Approval to Initiate Clinical Trial of

Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population, today announced that it has received ... [Market Wire via MSN Money - 11/02/2009]

Entities: Adeona, Copper, Alzheimer's Disease, Serum

First Reported 11/02/2009 - Updated 11/02/2009 - 1 Documents (in Internet & IT)

Wall Street News Alert: Trade Alert: AEN, HGSI, NVAX

Wall Street News Alert is issuing its "Daily Market Movers Report" for Monday morning. The list includes: Adeona Pharmaceuticals, Inc. (AMEX: AEN), Human Genome Sciences, Inc. (NASDAQ: HGSI) and Novavax, Inc. (NASDAQ: NVAX).For more information, please ... [Individual.com - 11/02/2009]

Entities: Adeona, Wall Street, Novavax Inc

First Reported 11/09/2009 - Updated 11/09/2009 - 1 Documents (in Health)

Adeona Launches CopperProof Test Panel

ANN ARBOR, MI -- (MARKET WIRE) Adeona Pharmaceuticals, Inc. (AMEX: AEN) announced today that it has initiated the U.S. launch of its high precision diagnostic test panel for the comprehensive evaluation of zinc and copper status in patients with Alzheimer's ... [Street Insider - 11/09/2009]

Entities: Adeona, Copper, Alzheimer's Disease, Serum

First Reported 11/13/2009 - Updated 11/13/2009 - 1 Documents

HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 13

(For large-cap stocks on the move, click on)Nov 13 (Reuters) - Some small and midcap stocks on the move on Friday:GREEN MOUNTAIN COFFEE ROASTERS, $69.21, up 1 pct The company acquired the wholesale business of Timothy's Coffees from an affiliate of private ... [Forbes.com - 11/13/2009]

Entities: Adeona, ICx Technologies Inc, Lakeland Financial Corporation, Maxygen Incorporated, TC PipeLines LP

First Reported 05/25/2009 - Updated 05/25/2009 - 1 Documents

Adeona Warns of Instability; OpenDHT Mothballed

The requested URL (/it.slashdot.org/article.pl?sid=09/05/24/2033249) was not found.If you feel like it, mail the url, and where ya came from to help@slashdot.org. ... [Slashdot - 05/25/2009]

Entities: Adeona

First Reported 07/20/2009 - Updated 07/20/2009 - 1 Documents (in Health)

Adeona Provides Results Of Clinical Study On Alzheimer's Disease

To evaluate serum markers of copper statusAdeona has provided results of a 90 subject prospective, blinded, observational clinical study to evaluate copper and zinc status in Alzheimer's disease, Parkinson's disease and normal subjects.The purpose of ... [Pharmaceutical Business Review - 07/20/2009]

Entities: Serum, Adeona, Copper

First Reported 10/19/2009 - Updated 10/19/2009 - 1 Documents

Form 8-K/A ADEONA PHARMACEUTICALS, For: Jul 09

Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++ADEONA+PHARMACEUTICALS%2C+++For%3A+Jul+09/5027128.html for the full story. ... [Street Insider - 10/19/2009]

Entities: Adeona, 8-k

Quotes

Max Lyon, President & Chief Executive Officer of Adeona, commented, "We are pleased with our progress in the third quarter and are particularly excited about the recent launch of our CopperProof™ test panel for helping physicians determine if their Alzheimer's and cognitive impairment patients have copper and zinc metabolic imbalances. Our acquisition of HartLab in July, gives us the opportunity to enter the market with the only comprehensive diagnostic test panel available for this purpose. Based on the new data we presented at the ICAD conference, combined with the existing peer reviewed data available, we believe that the comprehensive determination of copper and zinc status combined with the appropriate follow on therapeutic actions could have a significant impact on the progression of these diseases. We believe our recently announced clinical study with Zinthionein ZC will robustly demonstrate the value of this patent pending gastro-retentive, sustained release oral high dose zinc therapy in the Alzheimer's and cognitive impairment populations, which we plan to launch in the first quarter of 2010."

Adeona Pharmaceuticals Announces Third Quarter 2009 Results and Achievements [Freshnews.com - 11/17/2009]

Max Lyon, President & Chief Executive Officer of Adeona, commented, "We are pleased with our progress in the third quarter and are particularly excited about the recent launch of our CopperProof"

Adeona Pharmaceuticals Announces Third Quarter 2009 Results and Achievements [Yahoo! Canada - 11/17/2009]

Log in to Silobreaker

Advanced Search Options

Adeona